BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31741121)

  • 1. Long noncoding RNAs: emerging roles in pulmonary hypertension.
    Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Zhang Y; Luo Q; Liu Z
    Heart Fail Rev; 2020 Sep; 25(5):795-815. PubMed ID: 31741121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
    Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
    Han Y; Ali MK; Dua K; Spiekerkoetter E; Mao Y
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline.
    Sun Z; Liu Y; Yu F; Xu Y; Yanli L; Liu N
    Biomed Pharmacother; 2019 Jul; 115():108933. PubMed ID: 31060005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of Noncoding RNA in Pulmonary Hypertension.
    Deng L; Han X; Wang Z; Nie X; Bian J
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
    Zahid KR; Raza U; Chen J; Raj UJ; Gou D
    Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUG1 Regulates Pulmonary Arterial Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension.
    Wang S; Cao W; Gao S; Nie X; Zheng X; Xing Y; Chen Y; Bao H; Zhu D
    Can J Cardiol; 2019 Nov; 35(11):1534-1545. PubMed ID: 31679623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA Rps4l Mediates the Proliferation of Hypoxic Pulmonary Artery Smooth Muscle Cells.
    Liu Y; Zhang H; Li Y; Yan L; Du W; Wang S; Zheng X; Zhang M; Zhang J; Qi J; Sun H; Zhang L; Li G; Zhu D
    Hypertension; 2020 Oct; 76(4):1124-1133. PubMed ID: 32772647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
    Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
    Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNAs: novel links in respiratory diseases (review).
    Liu Y; Zhang R; Ying K
    Mol Med Rep; 2015 Jun; 11(6):4025-31. PubMed ID: 25647639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1.
    Sun W; Lv J; Duan L; Lin R; Li Y; Li S; Fu C; Zhao L; Xin S
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1038-1042. PubMed ID: 30551879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs as novel players in the pathogenesis of hypertension.
    Jiang X; Ning Q
    Hypertens Res; 2020 Jul; 43(7):597-608. PubMed ID: 32020084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats.
    Cao Y; Yang Y; Wang L; Li L; Zhang J; Gao X; Dai S; Zhang Y; Guo Q; Peng YG; Wang E
    Biomed Pharmacother; 2018 Oct; 106():1108-1115. PubMed ID: 30119177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of long non-coding RNAs in pulmonary hypertension and their molecular mechanisms (Review).
    Qin Y; Yan G; Qiao Y; Wang D; Luo E; Hou J; Tang C
    Exp Ther Med; 2020 Dec; 20(6):164. PubMed ID: 33093902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA Tug1 involves in the pulmonary vascular remodeling in mice with hypoxic pulmonary hypertension via the microRNA-374c-mediated Foxc1.
    Yang L; Liang H; Shen L; Guan Z; Meng X
    Life Sci; 2019 Nov; 237():116769. PubMed ID: 31422096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1.
    Jandl K; Thekkekara Puthenparampil H; Marsh LM; Hoffmann J; Wilhelm J; Veith C; Sinn K; Klepetko W; Olschewski H; Olschewski A; Brock M; Kwapiszewska G
    J Pathol; 2019 Mar; 247(3):357-370. PubMed ID: 30450722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of long non‑coding RNA ANRIL promotes proliferation and migration in hypoxic human pulmonary artery smooth muscle cells.
    Wang S; Zhang C; Zhang X
    Mol Med Rep; 2020 Feb; 21(2):589-596. PubMed ID: 31974617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction.
    Zhang JR; Sun HJ
    Hypertens Res; 2021 Feb; 44(2):129-146. PubMed ID: 32985618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.